Literature DB >> 16565219

Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.

M C J Bootsma1, O Diekmann, M J M Bonten.   

Abstract

Control of nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA) has been unsuccessful in most countries. Yet, some countries have maintained low endemic levels by implementing nationwide MRSA-specific infection control measures, such as "search &amp; destroy" (S&amp;D). These strategies, however, are not based on well designed studies, and their use in countries with high levels of endemicity is controversial. We present a stochastic three-hospital model and an analytical one-hospital model to quantify the effectiveness of different infection control measures and to predict the effects of rapid diagnostic testing (RDT) on isolation needs. Isolation of MRSA carriers identified by clinical cultures is insufficient to control MRSA. However, combined with proactive search (of high-risk patients on admission and/or contacts of index patients), it will maintain prevalence levels <1%. Concerted implementation of S&amp;D in countries with high nosocomial endemicity reduces nosocomial prevalence to <1% within 6 years. Stepwise implementation of control measures can reduce isolation capacities needed. RDT can reduce isolation needs by >90% in low-endemic settings and by 20% in high-endemic settings. Surveillance of colonization and improved hand hygiene can markedly increase control efficacy. These findings strongly suggest that: (i) causality exists between S&amp;D and low MRSA prevalence; (ii) isolating MRSA carriers identified by clinical cultures as a single measure is insufficient for control; (iii) a combined approach of isolation and screening confers efficacy; and (iv) MRSA-prevalence levels can be reduced to <1% in high-endemic settings by S&amp;D or a stepwise approach to interventions. RDT can markedly enhance feasibility.

Entities:  

Mesh:

Year:  2006        PMID: 16565219      PMCID: PMC1459403          DOI: 10.1073/pnas.0510077103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data.

Authors:  Hajo Grundmann; Satoshi Hori; Bob Winter; Adriana Tami; Daren J Austin
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

2.  Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage.

Authors:  A Scanvic; L Denic; S Gaillon; P Giry; A Andremont; J C Lucet
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

3.  Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.

Authors:  Nuno A Faria; Duarte C Oliveira; Henrik Westh; Dominique L Monnet; Anders R Larsen; Robert Skov; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Outbreak of methicillin-resistant Staphylococcus aureus in a Norwegian hospital.

Authors:  A Christensen; O Scheel; K Urwitz; K Bergh
Journal:  Scand J Infect Dis       Date:  2001

5.  Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.

Authors:  M H Reacher; A Shah; D M Livermore; M C Wale; C Graham; A P Johnson; H Heine; M A Monnickendam; K F Barker; D James; R C George
Journal:  BMJ       Date:  2000-01-22

6.  The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital.

Authors:  S Hori; R Sunley; A Tami; H Grundmann
Journal:  J Hosp Infect       Date:  2002-01       Impact factor: 3.926

7.  Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital.

Authors:  Janet Raboud; Refik Saskin; Andrew Simor; Mark Loeb; Karen Green; Don E Low; Allison McGeer
Journal:  Infect Control Hosp Epidemiol       Date:  2005-07       Impact factor: 3.254

8.  Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands.

Authors:  A M Kaiser; C Schultsz; G J Kruithof; Y Debets-Ossenkopp; C Vandenbroucke-Grauls
Journal:  Clin Microbiol Infect       Date:  2004-11       Impact factor: 8.067

9.  A purpose built MRSA cohort unit.

Authors:  F Fitzpatrick; O M Murphy; A Brady; S Prout; L E Fenelon
Journal:  J Hosp Infect       Date:  2000-12       Impact factor: 3.926

10.  The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.

Authors:  Sara E Cosgrove; Youlin Qi; Keith S Kaye; Stephan Harbarth; Adolf W Karchmer; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2005-02       Impact factor: 3.254

View more
  79 in total

1.  Surveillance and management of all types of Staphylococcus aureus bacteraemia.

Authors:  John Paul
Journal:  BMJ       Date:  2006-08-05

2.  Quantifying interhospital patient sharing as a mechanism for infectious disease spread.

Authors:  Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration.

Authors:  Erika M C D'Agata; Pierre Magal; Damien Olivier; Shigui Ruan; Glenn F Webb
Journal:  J Theor Biol       Date:  2007-08-25       Impact factor: 2.691

4.  Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use.

Authors:  Suzanne M Paule; Donna M Hacek; Bridget Kufner; Karine Truchon; Richard B Thomson; Karen L Kaul; Ari Robicsek; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

Review 5.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

6.  Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method.

Authors:  Diana F M Willemse-Erix; Maarten J Scholtes-Timmerman; Jan-Willem Jachtenberg; Willem B van Leeuwen; Deborah Horst-Kreft; Tom C Bakker Schut; Ruud H Deurenberg; Gerwin J Puppels; Alex van Belkum; Margreet C Vos; Kees Maquelin
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

7.  Cost-effective frozen master mix modification of a commercial methicillin-resistant Staphylococcus aureus PCR assay.

Authors:  Erik Munson; Timothy Block; Janet T Voegeli; Jeanne E Hryciuk; Ronald F Schell
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

8.  Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens.

Authors:  Angela S Rossney; Celine M Herra; Gráinne I Brennan; Pamela M Morgan; Brian O'Connell
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

9.  Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital.

Authors:  A M Strandén; R Frei; H Adler; U Flückiger; A F Widmer
Journal:  Infection       Date:  2008-10-30       Impact factor: 3.553

10.  Detecting and tracking nosocomial methicillin-resistant Staphylococcus aureus using a microfluidic SERS biosensor.

Authors:  Xiaonan Lu; Derrick R Samuelson; Yuhao Xu; Hongwei Zhang; Shuo Wang; Barbara A Rasco; Jie Xu; Michael E Konkel
Journal:  Anal Chem       Date:  2013-02-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.